Why the study?
Should nesiritide be used as a first-line agent for decompensated CHF compared to standard therapy like nitroglycerin?
Population
Patients with decompensated congestive heart failure (CHF)
Comparison
Nesiritide vs Nitroglycerin and standard drug therapy
Design
Editorial
Authors
Loading...
Nesiritide should be considered a second-line agent for decompensated CHF behind nitroglycerin and intravenous diuretics due to similar efficacy and safety but significantly higher cost.
Should nesiritide be used as a first-line agent for decompensated CHF compared to standard therapy like nitroglycerin?
Nesiritide should be considered a second-line agent for decompensated CHF behind nitroglycerin and intravenous diuretics due to similar efficacy and safety but significantly higher cost.
Noviasky et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: